BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25696857)

  • 1. Guidelines for quantifying iron overload.
    Wood JC
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):210-5. PubMed ID: 25696857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of magnetic resonance imaging to monitor iron overload.
    Wood JC
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):747-64, vii. PubMed ID: 25064711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Perspectives on Circulating Ferritin: Its Role in Health and Disease.
    Fonseca Ó; Ramos AS; Gomes LTS; Gomes MS; Moreira AC
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating tissue iron burden: current status and future prospects.
    Wood JC
    Br J Haematol; 2015 Jul; 170(1):15-28. PubMed ID: 25765344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results.
    Wood JC; Zhang P; Rienhoff H; Abi-Saab W; Neufeld EJ
    Magn Reson Imaging; 2015 Jul; 33(6):761-7. PubMed ID: 25708262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial.
    Wood JC; Pressel S; Rogers ZR; Odame I; Kwiatkowski JL; Lee MT; Owen WC; Cohen AR; St Pierre T; Heeney MM; Schultz WH; Davis BR; Ware RE;
    Am J Hematol; 2015 Sep; 90(9):806-10. PubMed ID: 26087998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell exchange: special focus on sickle cell disease.
    Kim HC
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):450-6. PubMed ID: 25696893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron age: novel targets for iron overload.
    Casu C; Rivella S
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):216-21. PubMed ID: 25696858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report.
    Sassi MB; Gaies E; Salouage I; Trabelsi S; Lakhal M; Klouz A
    Curr Drug Saf; 2015; 10(3):254-6. PubMed ID: 25968921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METABOLISM OF IRON STORES.
    Saito H
    Nagoya J Med Sci; 2014 Aug; 76(3-4):235-254. PubMed ID: 25741033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current Topics on Vitamin D. The role of active forms of vitamin D in regulation of bone remodeling].
    Nakamichi Y; Takahashi N
    Clin Calcium; 2015 Mar; 25(3):395-402. PubMed ID: 25716813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of gene amplification by PCR for the diagnosis of Mycoplasma pneumoniae infections in the child].
    Grattard F; Bourlet T; Galambrun C; Berger C; Stephan JL; Lauras B; Pozzetto B
    Pathol Biol (Paris); 1998 Jun; 46(6):464-9. PubMed ID: 9769883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A; Brown B; Herbert DE; Haynes J
    J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and the liver.
    Pietrangelo A
    Liver Int; 2016 Jan; 36 Suppl 1():116-23. PubMed ID: 26725908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE;
    Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I treat and manage strokes in sickle cell disease.
    Kassim AA; Galadanci NA; Pruthi S; DeBaun MR
    Blood; 2015 May; 125(22):3401-10. PubMed ID: 25824688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two novel potential markers for iron metabolism: hepcidin and non-transferrin-bound iron (NTBI)].
    Ikuta K
    Rinsho Ketsueki; 2015 Feb; 56(2):194-203. PubMed ID: 25765800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms.
    Breccia M; Voso MT; Aloe Spiriti MA; Fenu S; Maurillo L; Buccisano F; Tafuri A; Alimena G
    Ann Hematol; 2015 May; 94(5):771-7. PubMed ID: 25743685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.